Kachnar (Bauhinia variegata)
What Is Kachnar?
Kachnar is catalogued in the Materia Medica under the binomial Bauhinia variegata, a plant of the Fabaceae family, native to the tropics of Asia, Africa and the Americas. The material in circulation is bark, bud — bark, stripped from stem or trunk. The common name Kachnar and the botanical name Bauhinia variegata refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as faintly astringent, mildly sweet — a practical marker of freshness and correct identification.
The written history of Kachnar begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the bark, bud contains. Beyond its practical use it carries cultural associations — symbol of resilience in Punjabi folk poetry.
Today most searches for Kachnar come from people reading about congestion and thyroid, or checking how it sits alongside a medication they already take. The use most often documented in the literature is adjunct for benign thyroid nodules and goiter (Kanchanar Guggulu), followed by anti-inflammatory in lymphadenopathy.
How Does Kachnar Work?
Kachnar is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Quercetin, Kaempferol and Tannins. Quercetin is the fraction most often standardised in extracts, associated in the literature with anti-allergic and antioxidant flavonol. Kaempferol is discussed in relation to cardioprotective flavonol. Tannins is discussed in relation to astringent polyphenols with antimicrobial properties.
Traditional practice described Kachnar in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on bark: kaempferol, quercetin, tannins and lupeol. Where research exists, it examines adjunct for benign thyroid nodules and goiter (Kanchanar Guggulu), anti-inflammatory in lymphadenopathy and astringent for diarrhea. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Kachnar is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Kachnar is documented as interacting with thyroid replacement. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Kachnar can differ substantially; this is why reference entries specify bark, bud and, where they exist, standardisation markers.